Derek J Chong, MD, MSc, FRCPc Assistant Professor of Clinical Neurology Director, Clinical Neurophysiology Laboratory, Allen Pavilion site Director, Vanderbilt Epilepsy Clinic, New York Presbyterian Hospital Director, Clinical Trials, Columbia Comprehensive Epilepsy Center
Education:
MD: University of Calgary, Canada
Residency: University of Western Ontario, Canada
Fellowship: Comprehensive Epilepsy Center, Neurological Institute of New York, Columbia University
Board Certification: American Board of Neurology and Psychiatry Fellow of the Royal College of Physicians and Surgeons of Canada, FRCP(C), Division of Medicine, Specialist in Neurology
Office Locations: Neurological Institute 710 West 168th Street (btw Fort Washington and Haven Ave) 7th Floor New York, NY 10032 Phone: 212-305-1742 Fax: 212-305-4550
Allen Pavilion Columbia Presbyterian Medical Center 5141 Broadway 3RE-Suite 261 New York, NY 10034 Phone: 212-932-4254 Fax: 212-932-4873
Insurance: Aetna, CIGNA, Empire BC/BS-Wellchoice & Unicare, HIP, Neighborhood Health Providers, Oxford, PHS/Healthnet, United Healthcare, NYCHP, Medicare, Medicaid *Please verify insurance participation with the physician's office when making an appointment.
Doctor Chong was born and raised in Canada, attending McMaster University for his Bachelor's degree in biology, and following it with a Master's in Science in Brain and Behavior. His medical degree was completed at the University of Calgary and he was a resident and chief resident in neurology at the University of Western Ontario. He then spent 2 years training with the Columbia Comprehensive Epilepsy Center, focused on clinical neurophysiology (EEG, evoked potentials), clinical and surgical approaches to epilepsy. In addition to his current clinical responsibilities, a large portion of his time is devoted to research. He is Director of Clinical Trials at the Epilepsy Center, and is principal investigator in multiple projects. Current focus is on why seizures continue to occur in some people, despite using multiple medications. The studies range from investigating new therapies, to mechanisms and improving diagnostic tests. His current work is being supported by the American Epilepsy Society and the Milken Family Foundation.
